MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Assessing the Economic Impact of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Real-World Evidence Study Protocol

    D. Dai, J. Fernandes, L. Samuel, C. Lu, S. Reitmaier, A. Berk (Woonsocket, USA)

    Objective: To assess differences in healthcare resource utilization (HCRU) and costs between patients with essential tremor (ET) receiving transcutaneous afferent patterned stimulation (TAPS) therapy and…
  • 2024 International Congress

    Application of Neurophysiology in the Clinical Evaluation of Pediatric and Adolescent Patients with Tremor

    B. Lavenstein, P. Mcgurrrin, F. Vial, E. Akano, S. Attaripour, P. Panyakaew, A. Choi, L. Pesantez-Pacheco, H. Lin, M. Hallett (Bethesda, USA)

    Objective: We explored the utility of noninvasive electrophysiological tremor studies in patients referred  for evaluation by pediatric movement specialists  following their clinical assessment . The…
  • 2024 International Congress

    A better understanding of Paediatric Paroxysmal Movement Disorders

    S. Harvey, N. Allen, S. Byrne, B. Lynch, N. Mcsweeney, S. Neville, O. O'Mahony, M. O'Regan, D. O'Rourke, E. Reade, D. Webb, M. King, K. Gorman (Dublin, Ireland)

    Objective: To clinically characterise paroxysmal movement disorders (PxMD) and determine prevalence in a paediatric population for the first time. Background: Characterised by episodic involuntary movements,…
  • 2024 International Congress

    Daily-life Sensor Based Measurement of Tremor Presence and Amplitude

    K. Ocran, D. Hepp, J. van Hilten, V. Exadaktylos, R. Weijer (Leiden, Netherlands)

    Objective: To evaluate the association between conventional clinical ratings of tremor and one week sensor-based monitoring  of tremor in patients with Parkinson’s disease (PwPD). Background:…
  • 2024 International Congress

    Characteristics and Treatment Patterns of Patients Newly Diagnosed With Essential Tremor: A Retrospective Claims Database Analysis in the US

    J. Williams, R. Pahwa, L. Barbato, J. Lin, F. Tefos, A. Sillah, S. Thomas, F. Geng, Y. Pan, J. Friderici, S. Shah (Bakersfield, USA)

    Objective: To understand patient characteristics and real-world medication patterns of patients with essential tremor (ET) being initiated on treatment in the US. Background: ET is…
  • 2024 International Congress

    Prevalence of Phosphorylated Alpha-Synuclein in Skin Biopsies of Essential Tremor Patients

    S. Bellows, N. Vanegas Arroyave, J. Jankovic (Housont, USA)

    Objective: To examine the prevalence of phosphorylated alpha-synuclein in nerve fibers in patients with essential tremor (ET) and ET plus. Background: Although Essential Tremor (ET)…
  • 2024 International Congress

    Association of cognition and other clinical characteristics of individuals with Essential Tremors

    H. Khalil, M. Nazzal, A. Al-Sharman, D. Al-Shorafat, H. Al Refa’I, S. Obeidat, L. Samman, K. El-Salem (Doha, Qatar)

    Objective: To examine the correlation between cognition and other clinical characteristics (motor and non-motor) in people with Essential Tremor. To examine the correlation between cognition and…
  • 2024 International Congress

    Expanding the concept of “occupational dystonia”: data from the Italian Dystonia Registry

    V. Velucci, L. Di Lorenzo, R. Erro, I. Di Somma, M. Esposito, A. Trinchillo, D. Belvisi, G. Fabbrini, G. Ferrazzano, S. Idrissi, R. Pellicciari, L. Avanzino, F. Di Biasio, C. Terranova, V. Rizzo, A. Castagna, M. Ramella, F. Bono, M. Barillari, M. Altavista, L. Polidori, C. Lettieri, C. Artusi, C. Scaglione, P. Barbero, L. Magistrelli, M. Petracca, R. Ceravolo, G. Cossu, T. Schirinzi, G. Squintani, A. Gigante, A. Muroni, T. Ercoli, M. Mascia, A. Berardelli, G. Defazio (Bari, Italy)

    Objective: This study aimed to investigate whether certain occupations are associated with an increased risk of developing specific focal forms of idiopathic adult-onset dystonia (IAOD),…
  • 2024 International Congress

    TM9SF2 Knockdown Decreases Pathological Alpha-synuclein Aggregation In Vivo

    C. Sortwell, R. Kumaran, F. Manfredsson, C. Kemp, M. Benskey, J. Patterson, A. Stoll, J. Howe, N. Kuhn, K. Luk, M. Cookson (Grand Rapids, USA)

    Objective: To determine whether knockdown of transmembrane 9 super family 2 (TM9SF2) decreases the formation of alpha-synuclein inclusions and toxicity to nigral neurons in the…
  • 2024 International Congress

    Alpha-Synuclein and Mitochondria Quality Control in Parkinson’s Disease: A Literature Review

    L. Shen (State College, USA)

    Objective: To provide an overview of the current knowledge on alpha-synuclein (αS) interactions with mitochondrial quality control (MQC) pathways in Parkinson’s disease (PD). Background: The…
  • « Previous Page
  • 1
  • …
  • 346
  • 347
  • 348
  • 349
  • 350
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley